Other languages ORION Corp.

Equities

A271560

KR7271560005

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-04 pm EDT			5-day change	1st Jan Change
92,600 ^KRW	-2.11%		+0.33%	-20.24%

May. 16	ORION Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 13	ORION Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ORION Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15
ORION Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13
ORION Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Celcuity to Proceed With Phase 1b/2 Trial of Gedatolisib Plus Nubeqa, Signs Supply Agreement With Bayer	23-08-22
ORION Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-13
Marinus Pharmaceuticals Says European Commission Approves Ztalmy Oral Suspension	23-07-31
Orion Corporation Announces European Commission Approval of Ztalmy(R) for the Adjunctive Treatment of Epileptic Seizures Associated with CDKL5 Deficiency Disorder	23-07-31
ORION Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14
EU empfiehlt weitere Indikation für Bayer-Krebsmittel Nubeqa	23-01-27
Orion Corporation and Amneal Pharmaceuticals, Inc. Sign License Agreement with Amneal Pharmaceuticals, Inc. to Commercialise Amneal's Generic Products in Europe, Australia and New Zealand	23-01-04
FDA prüft neue Indikation für Bayer-Krebsmittel Nubeqa beschleunigt	22-05-03
Orion Results from an Ongoing Phase I/II CYPIDES Trial of ODM-208 Presented at ASCO-GU	22-02-18
Orion's Net Attributable Income Declines 4.3% in September Quarter	21-11-11
Les actions hésitantes, la Chine et les résultats en soutien	20-07-09
Orion : Bayer kommt mit Entwicklung von neuem Prostatakrebsmittel voran	18-10-24
AVIS D'ANALYSTES DU JOUR : Société Générale, Airbus, Publicis, Peugeot, Unilever	18-07-20
AVIS D'ANALYSTES DU JOUR : Aéroports de Paris, Teleperformance, Total, Ferrari, Ubisoft, Atos...	18-06-14
Orion : Plusieurs fonds en lice pour la filiale sud-coréenne de Tesco	15-07-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer